Using SGLT-2 inhibitor, a benzene derivative, instead of glucoamylamine, to prevent, slow down progress, delay or treat metabolic disorders in patients with neurochemicals; using a mixture of SGLT2 inhibitor and neurochemicals; and Sicily in Comprehensive Pharmacology

摘要

The invention relates to methods for preventing, slowing the progression of, delaying or treating metabolic disorders induced in patients by the treatment with neuroleptic agents comprising administering to the patients an SGLT2 inhibitor.